FDA Drug Recalls

Recalls / Class II

Class IID-1172-2017

Product

Daytrana (methylphenidate transdermal system) Delivers 15 mg over 9 hours (1.6 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5553-3

Brand name
Daytrana
Generic name
Methylphenidate
Active ingredient
Methylphenidate
Route
Transdermal
NDCs
68968-5552, 68968-5553, 68968-5554, 68968-5555
FDA application
NDA021514
Affected lot / code info
Lot: 80426 Exp. 10/17

Why it was recalled

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Recalling firm

Firm
Noven Pharmaceuticals, Inc.
Manufacturer
Noven Therapeutics, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
11960 SW 144th St, N/A, Miami, Florida 33186-6109

Distribution

Quantity
234,960 patches
Distribution pattern
Nationwide.

Timeline

Recall initiated
2017-08-30
FDA classified
2017-09-18
Posted by FDA
2017-09-27
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1172-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Daytrana · FDA Drug Recalls